Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

medopad

Connecting patients to doctors

April 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …
Feature
allergan

Allergan unveils second bout of Phase 3 success in migraine

April 30, 2018 Research and Development, Sales and Marketing Allergan, migraine, pharma, ubrogepant

Allergan has revealed new data from the second of two Phase 3 studies into the efficacy of its calcitonin gene-related …
News
18538_700x200

Navigating CMC Requirements during drug development and post-approval

April 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dia

This training will offer you the overview of the existing regulatory aspects of the CMC, and will also give you …
News
hans-bishop_2x

Juno CEO and Co-founder steps down in wake of Celgene acquisition

April 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Juno, appointment, pharma

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …
Appointment
john_reed

Sanofi makes ex-Roche scientist new R&D chief

April 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Sanofi, appointment, pharma

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

April 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, Fresenius, Shire, Takeda, arthritis, pharma

The year seems like it’s running away as we come to the end of April. It’s been a more tense …
News
lilly_entrance_web

Eli Lilly partners with Chinese institution to advance the nation’s diabetes and CVD care

April 27, 2018 Medical Communications, Research and Development China, Eli Lilly, cardiovascular disorders, cvd, diabetes, pharma, type 2 diabetes

EIi Lilly has announced plans to partner up with China’s National Center for Cardiovascular Diseases (NCCD), the nation’s institution responsible …
News
alexion_sign

Investigational Alexion drug proves non-inferior to Soliris in rare blood disease

April 27, 2018 Medical Communications, Research and Development Alexion, paroxysmal nocturnal haemoglobinuria, pharma, soliris

Alexion has lifted the curtain on new data for its C5 complement inhibitor ALXN1210, demonstrating its non-inferiority to another of …
News
becca

Health to hand

April 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Breast Cancer Care, biotech, drugs, pharma, pharmaceutical

Kristina Barrick is the Digital Innovation Manager at Breast Cancer Care and leads on the development of BECCA, the Breast …
Feature
newspapers_jon_s

UK media coverage vastly underrepresents older cancer patients and their risk, study finds

April 26, 2018 Medical Communications, Research and Development Cancer, Cancer Research UK, UK, University of Glasgow, pharma

A Cancer Research UK-funded study undertaken by the University of Glasgow has revealed that representation and coverage of cancer patients …
News
shutterstock_212432119

Lilly’s arthritis drug found to prevent potentially lethal stem cell transplant complications

April 25, 2018 Research and Development Cancer, Eli Lilly, JAK inhibitors, Stem cells, baricitinib, graft-versus-host disease, pharma

Researchers at St Louis Washington University School of Medicine have uncovered a promising extra application of a particular Janus Kinase …
News
hans-bishop_2x

Juno CEO and Co-founder steps down in wake of Celgene acquisition

April 25, 2018 Medical Communications, Research and Development Celgene, appointment, juno therapeutics, pharma

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …
News
phone_health

Novartis forges forward into digital pharma with FocalView app

April 25, 2018 Medical Communications, Research and Development FocalView, Novartis, biotech, drugs, pharma, pharmaceutical

There is a growing trend in big pharma to talk up the potential for digital technology to revolutionise operations and …
News
john_reed

Sanofi makes ex-Roche scientist new R&D chief

April 25, 2018 Medical Communications, Research and Development Roche, Sanofi, biotech, drugs, pharma, pharmaceutical

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …
News
china_block_001_takeda

$64bn Takeda-Shire mega merger inches closer to closing

April 25, 2018 Research and Development, Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

From March onwards, Takeda has been nudging a deal with Shire onwards through repeatedly improved offers, which has seen the …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026